Last reviewed · How we verify

ILIT with extract of causal allergen

Gachon University Gil Medical Center · Phase 1 active Biologic Quality 0/100

ILIT with extract of causal allergen is a Biologic drug developed by Gachon University Gil Medical Center. It is currently in Phase 1 development. Also known as: Active ILIT.

At a glance

Generic nameILIT with extract of causal allergen
Also known asActive ILIT
SponsorGachon University Gil Medical Center
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about ILIT with extract of causal allergen

What is ILIT with extract of causal allergen?

ILIT with extract of causal allergen is a Biologic drug developed by Gachon University Gil Medical Center.

Who makes ILIT with extract of causal allergen?

ILIT with extract of causal allergen is developed by Gachon University Gil Medical Center (see full Gachon University Gil Medical Center pipeline at /company/gachon-university-gil-medical-center).

Is ILIT with extract of causal allergen also known as anything else?

ILIT with extract of causal allergen is also known as Active ILIT.

What development phase is ILIT with extract of causal allergen in?

ILIT with extract of causal allergen is in Phase 1.

Related